Condition
Indolent Non-hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Indolent Non-hodgkin Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Indolent Non-hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating TAK-243 for advanced cancer treatment | Phase 1 | Bethesda, Maryland | Recruiting | Jan 25, 2024 |
| Effects of exercise on immune function in lymphoma patients | — | Scottsdale, Arizona and 1 other locations | Recruiting | May 26, 2023 |
| Combining acalabrutinib and obinutuzumab to treat untreated follicular lymphoma and indolent non-Hodgkin lymphomas | Phase 2 | Atlanta, Georgia | Recruiting | May 12, 2021 |
| Treatment using modified T cells for certain types of lymphoma | Phase 1 | Chapel Hill, North Carolina | Recruiting | Jan 10, 2020 |
All recruiting trials (4)
-
Evaluating TAK-243 for advanced cancer treatment
This study is testing a new drug called TAK-243 to see if it can safely help people with advanced cancer by looking at how it affects their tumors and overall health.
-
Effects of exercise on immune function in lymphoma patients
This study tests how short-term and long-term exercise affects the immune system and overall well-being of patients with certain types of lymphoma.
-
Combining acalabrutinib and obinutuzumab to treat untreated follicular lymphoma and indolent non-Hodgkin lymphomas
This study is testing if combining two treatments, acalabrutinib and obinutuzumab, can help people with untreated follicular lymphoma and other slow-growing non-Hodgkin lymphomas feel better and improve their quality of life.
-
Treatment using modified T cells for certain types of lymphoma
This study is testing a new treatment using modified immune cells to see if it can help people with certain types of lymphoma that haven't responded to other therapies.
Related topics
Quick answers
How many Indolent Non-hodgkin Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.